Pierre‐François Dupré

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

Jean‐Marc Classe, Virginie Bordes, L. Campion et al. · Journal of Clinical Oncology · 2008 · 262 citations · Full text

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean‐Marc Classe, Cécile Loaec, Pierre Gimbergues et al. · Breast Cancer Research and Treatment · 2018 · 257 citations

Surgical Oncology, Neoadjuvant Chemotherapy, Cancer Detection +11

Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial

Bruno Coudert, Jean‐Yves Pierga, Marie‐Ange Mouret‐Reynier et al. · The Lancet Oncology · 2014 · 139 citations

Breast Oncology, Medicine, Neoadjuvant Trastuzumab +8

Axillary Padding as an Alternative to Closed Suction Drain for Ambulatory Axillary Lymphadenectomy

Jean‐Marc Classe, Pierre‐François Dupré, T François et al. · Archives of Surgery · 2002 · 72 citations

US-guided Percutaneous Release of the Trigger Finger by Using a 21-gauge Needle: A Prospective Study of 60 Cases

Franck Lapègue, Aymeric André, Olivier Meyrignac et al. · Radiology · 2016 · 67 citations

21-Gauge Needle, Moderate Trigger Finger, Hand Trauma +12